leisure time -WSS

leisure time

author：comprehensive 2025-09-27 06:03:26 - browse：389

LONDON — In a bid to expand its pipeline of inflammation-targeting drugs, Sanofi said Tuesday it was acquiring California-based Inhibrx in a deal worth up to $2.2 billion.

The core of the deal is Inhibrx’s experimental therapy for AATD, a disease that progressively damages the lungs and liver. The medicine, INBRX-101, is designed to reduce inflammation and stave off further damage to the tissue. Inhibrx has completed Phase 1 testing of the drug and is enrolling patients in a Phase 2 trial.

Inhibrx’s other drug candidates, including its line of cancer-targeting immunotherapies, will be portioned out into a new company that will continue to be called Inhibrx. Mark Lappe, the founder and CEO of Inhibrx, will lead the spun-out company.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： An outrageous hospital charge: I paid $710 for an hour of babysitting

knowledge

WSS

Timeline: Special counsel's probe into Trump's handling of classified documents

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Ending health disparities requires full federal government, panel says

CDC: Cases of alpha

Astellas still sees hope in its gene therapy after four deaths

Surge of respiratory disease in China has likely explanation

Wikipedia

leisure time

entertainment

The high cost of giving birth even with insurance

Congress must reauthorize a committee to support older Americans

As demand for Covid shots wanes, Moderna seeks its next success

Hospitals look to new technology to keep health care workers safe

Duchenne breakthrough therapy leaves behind pioneering families

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

Medicare details structure of new drug price negotiation program

Timeline: Special counsel's probe into Trump's handling of classified documents

Duchenne breakthrough therapy leaves behind pioneering families

Biden to sign 'historic' executive order on how US military handles sexual assault cases

knowledge

Alexander Hamilton and the argument for universal insurance

Ransomware attacks on hospitals: Study outlines patient impact

Marc Tessier

Ransomware attacks on hospitals: Study outlines patient impact

Interest rates are at a 22

Congress must reauthorize a committee to support older Americans

leisure time

knowledge

entertainment

hotspot